Up to $1M is available from Accelerating Commercialisation to commercialise novel products, processes and services.
Accelerating Commercialisation is focused on helping start-up companies commercialise new technology.
Accelerating Commercialisation, formally called Commercialisation Australia, helps Australian entrepreneurs, researchers, inventors, start-ups, Commercialisation Offices and small and medium enterprises address the challenges associated with commercialising novel intellectual property.
Accelerating Commercialisation is a key offering under the Entrepreneurs’ Programme.
The objective of Entrepreneurs’ Programme is to drive business growth and competitiveness through support for business improvement and promoting economic growth through research connections and commercialisation.
Want to find out my tips to get the
Accelerating Commercialisation grant?
The objectives of the Accelerating Commercialisation program are:
- Speed to market – accelerating the commercialisation of novel intellectual property in the form of novel products, processes and services
- Entrepreneurship – creating new businesses based on novel intellectual property with high growth potential
- Return on Investment – facilitating greater commercial and economic returns from both public and private research and development investment to drive business growth and competitiveness
- Research – generate greater commercial and economic returns from both public and private sector research
How much can you get?
This Accelerating Commercialisation grant provides projects up to 50% of the expenditure to a maximum of:
- $250,000 for commercialisation offices and eligible partner entities
- $1,000,000 for all other applicants.
Accelerating Commercialisation Grant recipients will also receive Portfolio Services for the duration of the project.
Eligible Accelerating Commercialisation projects aim to achieve at least one of the following:
- Opportunity – Engage external professionals, for example to confirm the market opportunity, develop the business model, identify potential partners, develop an IP strategy, raise capital or prepare an Information Memorandum
- Development – Complete development of a novel product, process or service
- Viability – Prove commercial viability of a novel product, process or service to a customer, investor or strategic partner
- Sales – Make the first sales of the novel product, process or service in Australia or overseas
- Management – Engage a senior experienced executive to fill a key gap in the management team, which is essential to achievement of your commercialisation outcomes
Stage 1 – Expression of Interest
After you lodge your Accelerating Commercialisation EOI, a Commercialisation Advisor will review your proposal.
During the review of your EOI you may be asked for further information in support of your EOI.
The Commercialisation Adviser will provide you with initial guidance on your commercialisation project if you are considering an Accelerating Commercialisation Grant or your Commercialisation Strategy if you are considering a Portfolio Services application.
If you want to progress to a full Accelerating Commercialisation application, you may receive further feedback on the potential merits of your project or strategy.
You may receive this guidance and feedback in the form of a face-to-face meeting, a telephone conversation or other means of communication – whichever is most appropriate under the circumstances.
Stage 2 – Full Application
If you are invited to submit a full application for Accelerating Commercialisation you will need to score well on the following merits:
- Need for Funding – you need to demonstrate insufficient financing to fund the entire project and that it would be unreasonable to expect you to obtain funding from from alternative sources.
- Market Opportunity – the market need for the novel product, process or service is clearly defined. The strength of the IP (including novelty) has been well described.
- Value Proposition – A clear, concise and compelling value proposition, i.e. why the intended customer wants to buy the product, process or service.
- Execution Plan – A sound execution plan to capture the opportunity and manage the risks, including a clear set of objectives and a clearly defined path to market
- Management Capability – The applicant demonstrates an appropriate level of expertise in commercialisation management, project management and business management
- National Benefits – The project will improve Australia’s participation and competitiveness in the global economy.
Accelerating Commercialisation Grants cannot be used to support projects beyond the point of first sales. This is because if it can be proven that your company and its novel product, process or service can be sold commercially in a key market, then financing is more readily available.
First sales means that a company is able to demonstrate, consistent with its value proposition, market acceptance of its novel product, process or service in its key target market(s).
A Accelerating Commercialisation project that aims to make first sales or other commercial transactions in an overseas market is unlikely to be competitive unless:
- the overseas market is a key market for the novel product, process or service
- the need for funding is clearly established, especially where your novel product, process or service has already been sold in Australia.
If you apply to Accelerating Commercialisation, you will be connected to a Commercialisation Adviser.
Commercialisation Advisers are independent, professional advisers who will guide you along the pathway to commercialising your IP.
They can assist you by:
- Guidance – providing guidance with respect to Accelerating Commercialisation
- Access – assessing your needs and helping you to access expertise and specialist advice
- Assistance – guiding and assisting you through the commercialisation process
- Funding – exploring alternative means of financing your project
- Operations – guiding and assisting you in operational matters
- Mentoring – monitoring your progress
- Network – developing your professional networks, including by linking you to members of the Expert Network.
Each Commercialisation Adviser has extensive experience in commercialisation either having taken their own products, processes or services to market, or having held senior roles in companies commercialising novel products, processes or services.
The Accelerating Commercialisation Expert Network is a network of experienced people who can help you make important business connections and create opportunities for you to raise capital and enter new markets.
Members of the Expert Network include successful entrepreneurs, domain experts, professional investors and strategic corporations. They have extensive experience in management, commercialisation, capital markets and business development. Members offer knowledge, skills, insights and links to help you in bringing your novel product, process or service to market.
The Expert Network builds upon the support you will receive from your Commercialisation Advisers as a growing resource to help you reach the people you need to reach – faster.
- Accelerating Commercialisation – Expression of Interest
- Accelerating Commercialisation – Application Form
- Accelerating Commercialisation – Factsheet
- Accelerating Commercialisation – FAQ
- Accelerating Commercialisation – Guidelines
Software Commercialisation Examples
Osler Technology – $1.1M
Clinical Performance Platform
Osler Technology has developed a Clinical Performance Platform for medical practitioners to record, monitor and analyse their clinical practice. By ensuring clinicians are appropriately trained using mobile technology at the patient bedside, Osler Technology reduces preventable patient harm that results in additional operational cost, litigation and human toll across health systems. Accelerating Commercialisation support will be used to help Osler Technology Pty Ltd complete and secure further Beta trials; complete the development of the application’s commercial release, secure its first commercial customers and; develop an entry plan for international markets.
Advanced Agricultural Systems – $1.1M
SwarmFarm – The key to unlocking new farming systems
Advanced Agricultural Systems has developed autonomous, robotic machines for use in agriculture. This technology will save on labour, reduce farm costs, increase yields, use inputs more efficiently and reduce the environmental impacts of agriculture. The commercial weed spraying project is the key step towards the overall commercialisation of robots as part of a new proven farming system. Accelerating Commercialisation support will be used to help SwarmFarm commercialise agricultural robotics and create a new industry resulting in increased productivity, in both Australian and International agriculture.
The Yield Technology Solutions – $1.1M
Improving yields in the Oyster Industry
The Yield has developed innovative Internet of Things technology which is designed to improve oyster growers’ yields and profitability through reducing unnecessary harvest closures, improving labour scheduling and tracking food safety. Accelerating Commercialisation is helping The Yield commercialise its products enabling sales, investment and global licensing revenue. It will contribute to Australia’s global reputation for high quality food exports.
Bluedot Innovation – $0.9M
Bluedot Innovation has developed novel location-based software enabling a new generation of local-based commerce.
Commercialisation Australia funding will be used to engage expert service providers to help build a commercial strategy, and to validate the performance and benefits of this software with key commercial partners.
360 Knee Systems – ensuring best outcomes for patients
360 Knee Systems uses specialised 3D mapping to improve the experiences of patients undergoing knee replacement. With assistance from Accelerating Commercialisation, 360 Knee Systems is growing and looking to expand into new international markets.
The company believes in a holistic approach to treatment, and engages with patients at least three months before their surgery to conduct assessments that help better understand and meet the expectations of each patient.
As part of this process, 360 Knee Systems uses state of the art 3D mapping technology to customise surgery and treatment plans.
First, a CT scan is conducted to map the patient’s knee. This scan is loaded into a physics engine simulation environment, and the knee replacement is simulated.
Through a combination of Bayesian statistics networks, machine learning and artificial intelligence, data predictions are then made, allowing for customisation of the knee reconstruction procedure to ensure the best outcome for each patient.
360 Knee Systems use the mapping to support patients treatment for up to 18 months post-surgery after their knee reconstruction.
“If you were going to build a building or a plane, you’d run the design through a simulation to test the finished product and calculate error margins beforehand. In orthopaedics the process should be no different,” says Bede O’Connor, Managing Director, 360 Knee Systems.
Bede says the Accelerating Commercialisation grant has directly helped the company by giving them the confidence to invest in expansion that includes employing more people, at their Sydney based facility.
He says an indirect outcome was the increase in reputation and awareness that the company gained after it was announced they were successful in obtaining the grant.
“People take notice when you receive Accelerating Commercialisation funding, it’s a competitive grant, so when companies see you’ve been given money through the programme they take you more seriously, and they know you’re good at what you do.”
360 Knee Systems have received considerable interest from commercial manufacturers wanting to partner with the company.
In the past two years 360 Knee Systems have helped more than 3000 patients across Australia and have treated 200 patients in the United States.
The company is looking to rapidly expand their US customer base, and move into the Japanese market in the next 12 months.
“We are the best in the world at what we do, which is the combinational approach to orthopaedic surgery through computational science, data prediction and mechanical engineering,” Bede adds.
FitMachine – keeping our industrial machines in good health
An innovative company has taken inspiration from the Fitbit® to develop a machine sensor that will save time, money and even lives. MOVUS Australia Pty Ltd’s FitMachine® is used to track the health of machines—just like the Fitbit tracks the health of humans.
The development, deployment and commercialisation of the system is supported by $231,950 in funding through an Accelerating Commercialisation grant provided by the Australian Government’s Entrepreneurs’ Programme.
The FitMachine allows manufacturers to track critical factors like vibration, noise and temperature fluctuations in their machinery, giving greater insight into how fast the machinery is deteriorating and allowing maintenance teams to more quickly respond to problems.
Ten businesses specialising in agricultural, environmental and medical technology will receive $3.7 million in funding. The grants have been provided the through the Accelerating Commercialisation element of the Entrepreneurs’ Programme.
The latest funding offers will assist:
- Alares Systems in South Brisbane, QLD to commercialise its platform that captures and interprets court records for credit providers. The technology will help credit providers better manage their credit risk.
- AMS International Technologies in Fortitude Valley, QLD to commercialise their energy management products and services for the electricity consumer. The products help consumers, electricity retailers and distributors better manage the use of electricity.
- Chromoxyion in Karana Downs, QLD to commercialise their product nationally and internationally to the livestock industry. Their process increases the number of females born on pig and dairy farms, increasing profits and improving animal welfare.
- Direct Injection Systems in Toowoomba City, QLD to commercialise their products which reduce livestock stress and weight loss during transportation. They have developed a supplement called uCalm Export plus a water injection unit called the Nutripro.
- Environmental Water Solutions in Osborne Park, WA to commercialise a world-first chemical filtration system which protects people from contaminated water.
- Flex-G in Canberra, ACT to commercialise their high performance coolant which is specifically developed for the motorsport and electric vehicle market. The coolant will allow for improved battery life, faster charging and cold weather performance.
- Forwrd in Holland Park West, QLD to commercialise their product, Apello. The real-time messaging platform allows health professionals to securely and directly collaborate through messaging, referrals and handovers.
- Spark Breweries and Distilleries Kew, VIC to commercialise their patented and compact brewing machine for retail venues and craft brewers. The machine allows pubs, hotels and craft brewers to brew and sell their product on the same site.
- Ubaryon in Lismore, NSW to commercialise their metal separation technology. The technology improves safety and reduces environmental impact in the energy industry.
- Vantari in West Pennant Hills, NSW to develop their virtual cadaver technology to deploy and test with their strategic partners and customers. The virtual reality software will improve training delivery for doctors and improve patient outcomes.